Inactive Instrument

Insiders Roche Holding Ltd. Swiss Exchange

Equities

End-of-day quote Swiss Exchange Other stock markets
- ^CHF	-

Apr. 26	Roche: positive CHMP opinion for Alecensa	CF
Apr. 26	Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU	MT

Roche Expects Sales, Core Earnings Growth -- Update	Feb. 01	DJ
Roche Expects Sales, Core Earnings Growth	Feb. 01	DJ
Roche Named Third Most Sustainable Company on Dow Jones' Pharmaceuticals Index	Dec. 15	MT
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-15	RE
Bayer's new CEO plans to cut management jobs in prelude to overhaul	23-09-14	RE
Destiny Pharma picks interim CEO as Clark makes quick exit	23-05-25	AN
Roche Q1 sales down 7% as COVID-related business wanes	23-04-26	RE
Roche Holding AG Approves Board and Board Committee Changes	23-03-14	CI
Johnson & Johnson names ex-Sanofi executive as pharma, R&D vice president	23-02-13	RE
Bayer's new CEO: long-time Roche, Genentech executive, Bill Anderson	23-02-08	RE
Bayer Taps Roche's Bill Anderson as New CEO; Succession Due in Coming Months	23-02-08	DJ
Bayer picks outsider Anderson as CEO after investor pressure	23-02-08	RE
Bayer Appoints Former Roche Executive as CEO	23-02-08	MT
Roche Names CEO for Pharmaceuticals Unit	23-02-02	MT
Roche flags 2023 earnings decline on slump in COVID products	23-02-02	RE
Roche Holding AG Announces Executive Appointments	23-02-02	CI
Roche Seeks Internal Candidate To Succeed Pharmaceutical Unit's CEO	23-01-11	MT
Swiss Drugmaker Roche CEO To Take Over As Chairman In 2023	22-12-12	MT
Roche Holding Ag Announces Executive Changes	22-12-12	CI
Roche Diagnostics North America Announces Brad Moore as President, Effective January 1, 2023	22-12-05	CI

No results for this search

ROCHE HOLDING : In line quarterly results won’t cut it for Roche

April 24, 2024 at 11:50 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST